Search Results for "Breast Pap Test Trial"

15:11 EDT 26th October 2016 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

New breast cancer test could prevent women needing chemotherapy – breast cancer test could prevent women needing new breast cancer test could spare more women the trauma of chemotherapy, it is claimed. Scientists are calling...

Carbone clinical trials test dietary therapy for triple-negative breast cancer

(University of Wisconsin-Madison) A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low in an essential nutrient make...

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon a...

New test could spare women unnecessary chemotherapy – Scotsman

ScotsmanNew test could spare women unnecessary chemotherapyScotsmanA new genetic test for cancer could replace existing procedures such as mammograms. Picture: PA. AMY WATSON. 00:00 Monday 11 July 201...

Endopredict vs Oncotype Dx for Breast Cancer

  Posted on July 20, 2016 by Rohan Khandelwal, Indian Breast Cancer Surgeon, and Author of blor A new test, called EndoPredict, can predict the risk of a woman’s breast cancer spreading within 10 y...

Scientists developing new test for breast cancer

Scientists at The Australian National University (ANU) are working with researchers in France to develop a new potential way to detect and monitor breast cancer that could involve a simple blood test.

BI, Lilly hook up to test breast cancer combo

Boehringer Ingelheim and Lilly are teaming up again, this time to test the potent of a novel combination of two medicines for the treatment of breast cancer.

Common breast cancer test may not be worth the cost, study suggests

A new study by a UCLA researcher in collaboration with colleagues at Harvard and University of Texas Southwestern has found that a genomic test widely used to help determine whether women with a commo...

Matching PubMed Articles

Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.

Prognostic factors of ipsilateral breast tumor recurrence (IBTR) may change over time following breast-conserving therapy.

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.

Glucocorticoid receptor (GR) overexpression is associated with poor prognosis ER-negative breast cancer. GR antagonism with mifepristone increases chemotherapy-induced breast cancer cell death, theref...

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

Accelerated partial breast irradiation (APBI) is emerging as an alternative to whole-breast irradiation. This study presents the results of a prospective trial evaluating 3-dimensional conformal radio...

Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?

No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.

Breast-conserving surgery (BCS) followed by radiotherapy (RT) is an established treatment for women with T1-2N0 breast cancers. Since subgroups of patients have low ipsilateral breast tumour recurrenc...

Search Whole site using Google

Quick Search
Advertisement Advertisement